1 January 2022 in Russian Journal of Evidence-Based Gastroenterology
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить современные клинические особенности гастродуоденальных кровотечений язвенной этиологии по материалам Воронежского городского специализированного центра. МАТЕРИАЛ И МЕТОДЫ В основу исследования положен анализ результатов стационарного лечения 221 пациента с кровотечениями язвенной этиологии на базе городского центра желудочно-кишечных кровотечений (Центр) БУЗ Воронежской области «Воронежская городская клиническая больница скорой медицинской помощи №1» в 2020—2021 гг. РЕЗУЛЬТАТЫ Наиболее распространенными типами кровотечения у обследованных пациентов явились состоявшееся кровотечение — FIIC (47,1%), нестабильно остановившееся — FIIA—FIIB (30,3%), продолжающееся — FIA—FIB (13,1%), реже всего встречался тип FIII (9,5%). Чаще всего наблюдались легкая степень тяжести кровопотери (50,7%) и тяжелая кровопотеря (32,6%), средняя степень тяжести выявлена у 16,7% пациентов. Наличие Helicobacter pylori у больных с язвенной болезнью отмечено в 4 раза чаще, чем у больных с острыми гастродуоденальными язвами. В комплексном лечении пациентов с кровоточащими язвами использован разработанный в Центре персонализированный подход, основанный на повышении эффективности эндоскопического гемостаза и профилактики возобновления гастродуоденальных кровотечений. В основу подхода положен метод комбинированной эндоскопической терапии язвенного гастродуоденального кровотечения с включением в протокол лечения инновационных технологий цитопротективного воздействия гранулированным сорбентом Асептисорб-Д и порошкообразным гемостатиком Желпластан. ЗАКЛЮЧЕНИЕ Острые кровоточащие гастродуоденальные язвы и язвенная болезнь желудка и двенадцатиперстной кишки имеют клинические особенности, которые необходимо учитывать при выборе оптимальных методов лечения и профилактики возобновления кровотечений. Использование персонализированного подхода в лечении кровоточащих язв с применением инновационных технологий цитопротективного воздействия обеспечило эффективный эндогемостаз в 93,1% наблюдений, снизило частоту возобновления геморрагии до 4,07% и летальность до 3,2%.
13 April 2024 in Kuban Scientific Medical Bulletin
Background. Gastroduodenal ulcer bleeding continues to be a serious problem in modern emergency surgery. Early intensive therapy combined with endoscopic hemostasis remains crucial for successful treatment of patients with ulcerative hemorrhages. The problem of recurrent bleeding, which is recorded in 12–33% of cases, even when using combined methods of endoscopic hemostasis, is still the most difficult challenge in the treatment of patients with ulcerative bleeding. The search for new approaches in the endoscopic treatment of bleeding gastroduodenal ulcers is considered to be highly relevant.Description of clinical cases. The present paper describes the experience of using an alginate polymer polysaccharide hemostatic hydrogel in the complex treatment of two patients with unstable bleeding from duodenal ulcers. Patient B., 70 years old, with severe somatic pathology and a history of ulcers for 20 years, was admitted to the Voronezh City Clinical Emergency Hospital No. 1 with gastroduodenal ulcer bleeding. According to urgent esophagogastroduodenoscopy, the patient was diagnosed with a bleeding ulcer of the anterior wall of the duodenum with unstable bleeding (Forrest IIA). A large thrombosed vessel 2 mm in diameter was detected in the ulcer base. Patient K., 50 years old, suffering from type II diabetes mellitus for 4 years, was admitted to an emergency hospital with Forrest IIB bleeding from an extensive ulcerative defect of the duodenum. The complex treatment of patients involved a personalized approach using an alginate polymer polysaccharide hemostatic hydrogel during therapeutic endoscopy. After applying a powdered alginate hemostatic agent, a transparent hydrogel tightly fixed to the ulcer was formed on the surface of the ulcerative defect, which remained on the surface of the defect for up to 3–4 days and provided a prolonged hemostatic effect without any damaging effect on the ulcer and the surrounding mucous membrane of the duodenum. Transendoscopic application of an alginate polymer polysaccharide hemostatic hydrogel on the surface of a bleeding ulcer in the complex treatment of unstable ulcer bleeding prevented recurrent bleeding and ensured proper healing of the ulcer defect, thereby improving treatment results for patients with complicated peptic ulcer disease.Conclusion. Clinical observations have shown that the use of alginate polymer polysaccharide hemostatic hydrogels in combined endoscopic treatment of unstable gastroduodenal ulcer bleeding reliably prevents recurrence of hemorrhage, stabilizes the condition of patients in the early stages, improves the quality of healing of a bleeding ulcerative defect, thereby suggesting the prospects of use of this hemostatic in the treatment of gastroduodenal ulcer bleeding. However, the present paper describes only the first experience of the clinical use of hemostatic alginate polymer polysaccharide hemostatic hydrogel, which is to be analyzed in more details on a larger sample of patients.
23 April 2023 in Journal of Volgograd State Medical University
ВКВоронцов Алексей Константинович
Воронцов Алексей Константинович
+2
The problem of treating intra-abdominal bleeding in abdominal trauma is one of the most serious in urgent surgery. The most common cause of these hemorrhages is liver damage. For surgical hemostasis, local hemostatics and granular sorbents are becoming increasingly common. The aim of the study was to study in vivo the hemostatic properties and morphological features of the reparative regeneration of simulated bleeding liver wounds during treatment with the hemostatic agent Surgitamp and the sorbent Molselect G-50. The experiments were performed on 30 laboratory animals Chinchilla rabbits. After reproducing the model of a bleeding liver wound, bleeding was stopped in the experimental group (n = 15) by applying Molselect G-50 (4.0 g) powdered sorbent into the wound, followed by tamponing with Surgitamp hemostatic gauze (4.0 x 2.0 cm). Hemostasis in the control liver wound was carried out by applying a U-shaped suture with a PGA-3.0 thread until the edges of the wound converged. Morphological studies were performed on the 7th, 14th and 28th days of the experiment. Experimental studies have shown that the time to stop bleeding in the experimental group was 280.0 (264.0308.0) sec, in the control, the time of hemostasis was later 461.0 (420.0501.0) sec. Morphological studies have allowed us to establish differences in both the rate and quality of reparative regeneration of experimental simulated liver wounds compared with the control. Experimental studies using Molselect G-50 in combination with Surgistamp for local hemostasis of bleeding liver wounds in rabbits allowed us to conclude that such a combination makes it possible not only to reliably stop bleeding, but also promotes the stimulation of reparative regeneration.
23 September 2017 in Journal of Experimental and Clinical Surgery
ECEvgeny Fedorovich Cherednikov
Evgeny Fedorovich Cherednikov
ГАГлухов Александр Анатольевич
Глухов Александр Анатольевич
+1
Relevance. Gastroduodenal ulcer bleeding is one of the most complex problems of emergency abdominal surgery. An endoscopic hemostasis is a crucial importance during the treatment of patients with gastroduodenal bleeding. The using of biologically active draining sorbents in combination with local haemostatic drugs is a promising direction in the endoscopic hemostasis.Objective. The aim of the investigation is to improve the results of treatment of patients with acute ulcerative gastroduodenal hemorrhages by application of biologically active draining of sorbent Asepticob-A in combination with platelet-rich plasma for endoscopic hemostasis as an important component of complex therapy.Materials and methods. The study is based on the results of treatment of 112 patients with peptic ulcer bleeding. They were treated in the specialized city centre for the treatment of patients with gastrointestinal bleeding of Voronezh state hospital of emergency medical care №1. During the treatment of patients of the main group (n=57 persons) was used individual complex approach with the using of biologically active draining of sorbent of new generation – Asepticob-A and platelet-rich plasma in endoscopic treatment of bleeding complications of gastroduodenal ulcers. In the comparison group (n=55 persons) was used the well-known traditional methods of endoscopic hemostasis without the use of granular sorbents and platelet-rich plasma.Results and discussion. The effectiveness of treatment of patients with ulcerative gastroduodenal bleeding was assessed according to the criteria of reliability of hemostasis, assessment of dynamics of reparative processes in ulcerous defects, the frequency of recurrence of bleeding on the background of treatment using endoscopic techniques, prevention, emergency operations and mortality rate. The methods of treatment of gastroduodenal bleeding with the combined use of biologically active draining sorbents and platelet-rich plasma for the reliability of endoscopic haemostasis, that was developed and introduced into clinical practice, reduces the number of emergency operations in 2.6 times, mainly due to the reduction of recurrent bleeding and, as a consequence, leads to lower postoperative mortality.Conclusions. The use of biologically active draining of sorbent Asepticob-A and platelet-rich plasma in complex endoscopic treatment of patients with ulcerative gastroduodenal bleeding allows to reduce the frequency of recurrence of bleeding from 10.9% to 3.5% (3.1 times), to reduce the number of emergency surgical interventions at the height of bleeding from 9.1% to 3.5% (2.6 times), to reduce postoperative mortality from 5.45% to 1.75% (3.1 times) and reduce the duration of inpatient treatment from 9.0 to 6.0 days (p<0.05).
20 June 2024 in Russian Journal of Evidence-Based Gastroenterology
Objective. This study aimed to investigate the morphology of the healing process dynamics in simulated bleeding stomach defects (BSD) during endoscopic treatment with alginate polymer polysaccharide hemostatic hydrogel (APPHH). Material and methods. The study involved 12 large laboratory animals (dogs). The experimental model of BSD, developed by E.F. Cherednikov et al., was utilized. Endoscopic hemostasis in experimental BSD was performed by pneumatic flow insufflation of powdered APPHH onto the bleeding defect (Patent RU №2762120). Control BSD were left untreated. Evaluation criteria included hemostasis time and assessment of macroscopic and microscopic features of BSD healing. Results. The hemostasis time with APPHH in endoscopic treatment of experimental BSD was 6.0 (4.0—8.0) seconds. Spontaneous hemostasis in control BSD occurred at 26.5 (25.3—32.0) seconds. Assessment of BSD healing processes revealed faster and more favorable regeneration in experimental BSD compared to control BSD, evidenced by macroscopic changes and morphological confirmation of mucosal changes at the BSD edges. Pathomorphological examination of gastrobiopsies showed no damage to stomach tissue by APPHH. Conclusion. Experimental studies demonstrate that APPHH reduces simulated bleeding cessation time, improves BSD healing quality, and does not damage gastric mucosa. This suggests potential clinical application in treating ulcerative gastrointestinal bleeding.
3 April 2023 in Journal of Experimental and Clinical Surgery
ПАПархисенко Юрий Александрович
Пархисенко Юрий Александрович
+1
The aim of the study was to investigate the potential of Surgitamp hemostatic gauze and Molselect G-50 sorbent application in surgical hemostasis of simulated bleeding liver wounds in an in vivo experiment on laboratory animals. Materials and methods. The study included 30 laboratory animals: Chinchilla rabbits. Laboratory animals underwent median laparotomy under intravenous anesthesia (Zoletil 100 0.1 ml /kg, Xylavet 0.1 ml/kg), the right lobe of the liver was involved into the wound. At a 20 cm distance from the surface of the liver, a metal 92 g load in the form of a triangular prism was attached to the slider with the help of a thread. By operational readiness, the thread was burned, the prism fell vertically and hit the surface of the liver with a pointed end, this resulting in a simulated bleeding liver wound: a wound of the right lobe of the liver, linear in shape 3.0x0.7 cm, 0.6 cm deep, with uneven edges and active bleeding from the defect area. Hemostasis in the experimental group of animals (n=15) was carried out by covering the wound surface with a granular sorbent Molselect G-50, followed by tamponing the wound with a strip of hemostatic gauze Surgitamp. In the control group of animals (n=15) hemostasis was carried out by stitching a bleeding liver wound with a U-shaped suture with a PHA 3.0 thread until the edges of the wound converged. The effectiveness of hemostasis of the liver wounds was evaluated using the following parameters: the time of the final bleeding arrest, the volume of blood loss, the number of episodes of repeated bleeding. Results. Experimental studies have demonstrated that the surgical hemostasis technique with the hemostatic agent Surgitamp application combined with the granular sorbent Molselect G-50 allows for reliable hemostasis of simulated bleeding liver wounds, reducing the time of bleeding arrest from 461.0(420.0-501.0) sec to 280.0(264.0-308.0) sec (P=0.0001), simultaneously reducing the incidence of recurrent hemorrhages from 46.7% to 6.7% (P=0.035).